Click for next page ( 144


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 143
Appendix C Committee Meetings First Meeting April 1-2, 2002 Washington, D.C. Meeting Objectives: Introduce National Research Council procedures; committee introductions and composition/balance/bias discussions; committee and report procedures; discuss genesis of the study and Statement of Task; discuss draft report outline; discuss project plan and report realization; receive overview briefing on the current U.S. regulatory environment; determine objectives and date of next com- mittee meeting. Presenters Analysis of the current (U.S.) regulatory environment: "Select Agent Rule," RAC/IRB Rules and Practices, Effectiveness/Enforcement of Current (U.S.) Biotechnology Rules and Practices Joseph G. Perpich Perpich and Associates, Inc. Ronald Atlas American Society for Microbiology 143

OCR for page 143
44 APPENDIX C The view from "The Hill" - Congressional perspectives on poten- tially dangerous biotechnology research and pathogens Stephen Redhead Congressional Research Service View from the Executive Branch: "Safeguarding Information Re- garding Weapons of Mass Destruction" - Office of Homeland Se- curity, Executive Office of the President Penrose (Parney) C. Albright Office of Homeland Security Office of Science and Technology Policy Rachel Levinson Office of Science and Technology Policy "Protective Oversight of Biotechnology: A Discussion Paper" John Steinbruner University of Maryland Second Meeting June 24-25, 2002 Washington, D.C. Meeting Objectives: Introduce new members and complete composi- tion/balance/bias discussion; discuss draft report outline; receive briefings on defining the problem, safeguarding information and governmen- tal challenges; make writing assignments; determine objectives and date of next committee meeting. Presenters Defining the Universe of Potentially Dangerous Biotechnology Re- search Gerald Epstein Defense Threat Reduction Agency Clarence J. Peters, Professor University of Texas at Galveston

OCR for page 143
APPENDIX C Mark Wheelis, Professor University of California at Davis Safeguarding Information in the Life Sciences Steven M. Block, Professor Stanford University Eugene B. Skoluikoff, Professor Massachusetts Institute of Technology 145 The Life Sciences Community and the Safeguarding of Scientific Knowledge: Challenges for Government Guy Roberts Department of the Navy R. Timothy Mulcahy, Associate Dean and Professor University of Wisconsin, Madison Steven Aftergood, Senior Research Analyst Federation of American Scientists Third Meeting September 9-10, 2002 Washington, D.C. Meeting Objectives: Receive briefings on "science and security issues" and the current thinking on "information security"; discuss chapter drafts; make writing assignments; determine objectives and date of next committee meeting. Presenters Defining Potentially Dangerous Research in the Life Sciences Malcolm Dando University of Bradford, U.K.

OCR for page 143
146 Defining "Sensitive" Information in the Life Sciences Parney Albright Office of Science and Technology Policy Rachel Levinson Office of Science and Technology Policy APPENDIX C Defining "Sensitive" Information in the Life Sciences The NIH Perspective Anthony Fauci, Director National Institute of Allergy and Infectious Disease National Institutes of Health "Life Sciences Research in International Security: Policy Developments for Responsible Use of 'Dual-Use' Knowledge" George Poste Health Technology Networks Biological Weapons Working Group U.K. Consultation Overview fohn Steinbruner University of Maryland Fourth Meeting October 8, 2002 Washington, D.C. Meeting Objectives: Review of contents, structure and substance of draft chapters; discuss report plan and status; make writing assign- ments; determine objectives and date of next committee meeting. No Presenters

OCR for page 143
APPENDIX C Fifth Meeting November 11, 2002 Washington, D.C. 147 Meeting Objectives: Review of contents, structure and substance of draft chapters; discuss report plan and status; make writing assign- ments; determine objectives and date of next committee meeting. No Presenters Sixth Meeting January 29, 2003 Washington, D.C. Meeting Objectives: Review of contents, structure and substance of draft chapters; discuss report plan and status; make writing assign- ments. No Presenters

OCR for page 143